Publication | Closed Access

An aptamer-antibody complex (oligobody) as a novel delivery platform for targeted cancer therapies

Cell-based Drug DeliveryNanomedicineDrug TargetingEngineeringTargeted Cancer TherapiesPolymer-drug ConjugateImmunologyAptamer-antibody ComplexNovel Delivery PlatformTumor TargetingTargeted TherapySite-specific DeliveryImmunotherapyMedicineBiomolecular Engineering